IMRT Course 2016

Cohort 1: Limb soft tissue sarcoma (110 patients) Does use of IMRT reduce late toxicity? Primary endpoint: rate of grade 2+ late soft tissue fibrosis at 2 years following radiotherapy (aim to reduce IMRiS: Intensity Modulated Radiotherapy in Sarcoma from 30% to 20%) Secondary endpoints: acute and late toxicity, patient reported limb function and quality of life, wound complications, time to local recurrence

32